About Quintiles Drug Research Unit
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Autoimmune Technologies, LLC
1
BTG International Inc.
1
Destiny Pharma Plc
1
PharmAthene UK Limited
1
PowderMed
1
Clinical Trials at Quintiles Drug Research Unit
During the past decade, Quintiles Drug Research Unit conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of the Ability of a Flu Vaccine to Prevent Flu Infection
2006-09-01
2007-01-01
Completed
105
Open-label Safety and Tolerability Study of CoVaccine HT™ in Healthy Volunteers
2009-11-01
2010-06-01
Completed
50
Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects
2014-09-01
2014-11-01
Completed
60
Safety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge Strain
2015-09-01
2016-06-01
Completed
79
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Quintiles Drug Research Unit" #1 sponsor was "Autoimmune Technologies, LLC" with 1 trials, followed by "BTG International Inc." with 1 trials
sponsored, "Destiny Pharma Plc" with 1 trials sponsored, "PharmAthene UK Limited" with 1 trials sponsored and "PowderMed"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Quintiles Drug Research Unit"
#1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Quintiles Drug Research Unit
According to Clinical.Site data, the most researched conditions in "Quintiles Drug Research Unit" are
"Influenza" (2 trials), "Prevention of Bacillus Anthracis (Anthrax) Infection" (1 trials), "Staphylococcus Aureus Infection" (1 trials) and "Vaccine" (1 trials). Many other conditions were trialed in "Quintiles Drug Research Unit" in a lesser frequency.
Clinical Trials Intervention Types at Quintiles Drug Research Unit
Most popular intervention types in "Quintiles Drug Research Unit" are "Biological" (3 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Chlorhexidine gluconate 2% topical cloths" (1 trials), "CoVaccine HT" (1 trials), "FF-3 dry powder" (1 trials), "Placebo" (1 trials) and "Placebo nasal gel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Quintiles Drug Research Unit
The vast majority of trials in "Quintiles Drug Research Unit" are
5 trials for "All" genders.
Clinical Trials Status at Quintiles Drug Research Unit
Currently, there are NaN active trials in "Quintiles Drug Research Unit".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Quintiles Drug Research Unit,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Quintiles Drug Research Unit, 3 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".